Sirtuins in vascular diseases: Emerging roles and therapeutic potential

被引:82
作者
D'Onofrio, Nunzia [1 ]
Vitiello, Milena [1 ]
Casale, Rosario [1 ]
Servillo, Luigi [1 ]
Giovane, Alfonso [1 ]
Balestrieri, Maria Luisa [1 ]
机构
[1] Univ Naples 2, Dept Biochem Biophys & Gen Pathol, Sch Med & Surg, I-80138 Naples, Italy
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2015年 / 1852卷 / 07期
关键词
Sirtuins; Endothelium; Vascular dysfunction; Endothelial progenitor cell; Cardiovascular disease; ENDOTHELIAL PROGENITOR CELLS; SMALL-MOLECULE ACTIVATORS; SMOOTH-MUSCLE-CELLS; OXIDATIVE-STRESS; SIRT1; ACTIVATOR; LIFE-SPAN; DOWN-REGULATION; DNA-DAMAGE; TNF-ALPHA; RED WINE;
D O I
10.1016/j.bbadis.2015.03.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Silent information regulator-2 (Sir-2) proteins, or sirtuins, are a highly conserved protein family of histone deacetylases that promote longevity by mediating many of the beneficial effects of calorie restriction which extends life span and reduces the incidence of cancer, cardiovascular disease (CVD), and diabetes. Here, we review the role of sirtuins (SIRT1-7) in vascular homeostasis and diseases by providing an update on the latest knowledge about their roles in endothelial damage and vascular repair mechanisms. Among all sirtuins, in the light of the numerous functions reported on SIRT1 in the vascular system, herein we discuss its roles not only in the control of endothelial cells (EC) functionality but also in other cell types beyond EC, including endothelial progenitor cells (EPC), smooth muscle cells (SMC), and immune cells. Furthermore, we also provide an update on the growing field of compounds under clinical evaluation for the modulation of SIRT1 which, at the state of the art, represents the most promising target for the development of novel drugs against CVD, especially when concomitant with type 2 diabetes. (C) 2015 Published by Elsevier B.V.
引用
收藏
页码:1311 / 1322
页数:12
相关论文
共 130 条
[1]   Poor glycaemic control in type 2 diabetes patients reduces endothelial progenitor cell number by influencing SIRT1 signalling via platelet-activating factor receptor activation [J].
Balestrieri, M. L. ;
Servillo, L. ;
Esposito, A. ;
D'Onofrio, N. ;
Giovane, A. ;
Casale, R. ;
Barbieri, M. ;
Paolisso, P. ;
Rizzo, M. R. ;
Paolisso, G. ;
Marfella, R. .
DIABETOLOGIA, 2013, 56 (01) :162-172
[2]   Effect of low doses of red wine and pure resveratrol on circulating endothelial progenitor cells [J].
Balestrieri, Maria Luisa ;
Schiano, Concetta ;
Felice, Francesca ;
Casamassimi, Amelia ;
Balestrieri, Antonio ;
Milone, Lara ;
Servillo, Luigi ;
Napoli, Claudio .
JOURNAL OF BIOCHEMISTRY, 2008, 143 (02) :179-186
[3]   High glucose downregulates endothelial progenitor cell number via SIRT1 [J].
Balestrieri, Maria Luisa ;
Rienzo, Monica ;
Felice, Francesca ;
Rossiello, Raffaele ;
Grimaldi, Vincenzo ;
Milone, Lara ;
Casamassimi, Amelia ;
Servillo, Luigi ;
Farzati, Bartolomeo ;
Giovane, Alfonso ;
Napoli, Claudio .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2008, 1784 (06) :936-945
[4]   Effect of red wine antioxidants and minor polyphenolic constituents on endothelial progenitor cells after physical training in mice [J].
Balestrieri, Maria Luisa ;
Fiorito, Carmela ;
Crimi, Ettore ;
Felice, Francesca ;
Schiano, Concetta ;
Milone, Lara ;
Casamassimi, Amelia ;
Giovane, Alfonso ;
Grimaldi, Vincenzo ;
del Giudice, Vincenzo ;
Minucci, Pellegrino Biagio ;
Mancini, Francesco Paolo ;
Servillo, Luigi ;
D'Armiento, Francesco Paolo ;
Farzati, Bartolomeo ;
Napoli, Claudio .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 126 (02) :295-297
[5]  
Balestrieri ML, 2014, DIABETES
[6]   Are sirtuins viable targets for improving healthspan and lifespan? [J].
Baur, Joseph A. ;
Ungvari, Zoltan ;
Minor, Robin K. ;
Le Couteur, David G. ;
de Cabo, Rafael .
NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (06) :443-461
[7]   Structure and Evolution of Human Sirtuins [J].
Bordo, Domenico .
CURRENT DRUG TARGETS, 2013, 14 (06) :662-665
[8]   Nicotinamide phosphoribosyltransferase imparts human endothelial cells with extended replicative lifespan and enhanced angiogenic capacity in a high glucose environment [J].
Borradaile, Nica M. ;
Pickering, J. Geoffrey .
AGING CELL, 2009, 8 (02) :100-112
[9]   NAD+, Sirtuins, and Cardiovascular Disease [J].
Borradaile, Nica M. ;
Pickering, J. Geoffrey .
CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (01) :110-117
[10]   Sirtuin activators: Designing molecules to extend life span [J].
Camins, Antoni ;
Sureda, Francesc X. ;
Junyent, Felix ;
Verdaguer, Ester ;
Folch, Jaume ;
Pelegri, Carme ;
Vilaplana, Jordi ;
Beas-Zarate, Carlos ;
Pallas, Merce .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2010, 1799 (10-12) :740-749